Centessa Pharmaceuticals plc

Ownership Transactions Reported by 25 Insiders

Symbol
CNTA on Nasdaq
Location
3 Rd Floor, 1 Ashley Road, Altrincham, Cheshire, United Kingdom

Insiders trading volume in the past year

Centessa Pharmaceuticals plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Saurabh Saha Chief Executive Officer, Director $13.5M -$3.57M -20.9% Sep 10, 2024
David J. Grainger Chief Innovation Officer $7.88M Dec 31, 2023
Antoine Yver EVP & Chairman of Development $6.23M Jun 1, 2023
Gregory M. Weinhoff Chief Business Officer $3.8M -$1.25M -24.8% Sep 10, 2024
David M. Chao Chief Administrative Officer $2.37M Jun 30, 2024
Francesco De Rubertis Director $2.24M Mar 21, 2022
Medicxi Ventures Management (Jersey) Ltd 10%+ Owner $2.24M Mar 21, 2022
Iqbal J. Hussain General Counsel $1.9M Jun 30, 2024
Thomas Templeman Chief Technology Officer $1.5M Mar 31, 2023
Tia L. Bush Chief Technology & Quality Ofc $1.48M Jun 30, 2024
Javad Shahidi Chief Medical Officer $1.27M Sep 30, 2022
Index Ventures Life Vi (Jersey) L.P. 10%+ Owner $1.19M May 27, 2021
Karen M. Anderson Chief People Officer $873K -$608K -41.1% Mar 25, 2024
Harris Rotman SVP Regulatory Affairs $507K -$270K -34.8% Feb 1, 2024
Aaron Kantoff Director $478K Nov 18, 2021
Marella Thorell Chief Accounting Officer $423K Mar 21, 2022
Mathias Hukkelhoven Director Jun 25, 2024
John J. Crowley Chief Financial Officer Jul 1, 2024
Mary Lynne Hedley Director Jun 25, 2024
GAP (Bermuda) L.P. Director, 10%+ Owner Jun 22, 2023
Samarth Kulkarni Director Jun 25, 2024
Robert Califf Director May 27, 2021
I. Zbar Brett Director Jun 25, 2024
Arjun Goyal Director Jun 25, 2024
Carol Stuckley Director Jun 25, 2024

Recent Insider Transactions by Companies or Individuals for Centessa Pharmaceuticals plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.